Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Naphazoline (Naphcon-a) is a sympathomimetic compound with marked alpha adrenergic activity. Naphazoline can be used as a vasoconstrictor with a rapid action in reducing swelling when applied to mucous membrane.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 11,500 | |||
10 mg | 在庫あり | ¥ 16,000 | |||
25 mg | 在庫あり | ¥ 26,500 | |||
50 mg | 在庫あり | ¥ 38,500 | |||
100 mg | 在庫あり | ¥ 57,000 | |||
500 mg | 在庫あり | ¥ 123,000 |
説明 | Naphazoline (Naphcon-a) is a sympathomimetic compound with marked alpha adrenergic activity. Naphazoline can be used as a vasoconstrictor with a rapid action in reducing swelling when applied to mucous membrane. |
別名 | AK-Con, Naphcon-a, Clear Eyes, All Clear |
分子量 | 210.27 |
分子式 | C14H14N2 |
CAS No. | 835-31-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (237.79 mM)
H2O: Insoluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Naphazoline 835-31-4 GPCR/G Protein Neuroscience Adrenergic Receptor Inhibitor TNFR AK-Con vascular hyperpermeability Interleukin Related decongestive Naphcon-a vasoconstriction Tumor Necrosis Factor Receptor cytokines VEGFR Clear Eyes Vascular endothelial growth factor receptor inflammation All Clear inhibit Naphthazoline TNF Receptor Beta Receptor conjunctivitis inhibitor